J.Pharma · Fitness & Performance · Research Peptide

MOTS-C

Mitochondrial-derived peptide encoded in the 12S rRNA gene. AMPK activation, insulin sensitivity, and metabolic regulation — available in 10mg and 40mg.

99%+ Purity Third-Party Tested US-Based Free Shipping COA Available
🧪 99%+ Purity Lab Certified
🇺🇸 US-Based Fast Dispatch
📦 Discreet Plain Packaging
🚚 Free Shipping All Orders
📋 COA Available on Request

About MOTS-C

MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino acid peptide encoded within the mitochondrial genome — specifically in the 12S rRNA gene. This makes it unusual among research peptides in that it originates from mitochondrial rather than nuclear DNA. Its discovery in 2015 opened new research directions into mitochondria-to-nucleus communication.

MOTS-C research has demonstrated activation of the AMPK (AMP-activated protein kinase) pathway — a central regulator of cellular energy homeostasis. Through AMPK activation, MOTS-C has been studied for its effects on glucose uptake, fatty acid oxidation, and insulin sensitivity. Research in rodent models has shown significant metabolic effects including improved insulin sensitivity, enhanced fat oxidation, and modulation of the folate cycle and one-carbon metabolism. Its natural levels decline with age, paralleling the general mitochondrial dysfunction associated with aging.

Purity
≥99%
HPLC-UV verified
Identity
LC-MS Confirmed
Mass spectrometry
Form
Lyophilized Powder
Requires reconstitution
Storage
Lyophilized: Room temp or 2–8°C
After reconstitution: 2–8°C
Available Sizes
10mg
Lyophilized powder · 99%+ purity
$50
Order →
40mg
Lyophilized powder · 99%+ purity
$155
Order →
🧪 Reconstitution
Reconstitute with Bacteriostatic Water. For 10mg: add 1 mL BAC Water (10 mg/mL). For 40mg: add 4 mL BAC Water (10 mg/mL). Solution is clear and colorless. Inject BAC Water slowly down the vial wall. Swirl gently. Refrigerate at 2–8°C after reconstitution. Stable 28–42 days. Visit our full Reconstitution Guide and Dosing Calculator for detailed instructions.

Research Applications

MOTS-C is used in research investigating AMPK pathway activation, mitochondrial function, insulin resistance, glucose metabolism, fat oxidation, aging biology, and mitochondria-to-nucleus signaling. It is of interest in research exploring the mitochondrial genome as a source of biologically active peptides distinct from nuclear-encoded proteins.

For research use only. All products sold by J.Pharma are intended strictly for in vitro laboratory research. Not for human or veterinary use. Not FDA approved for any therapeutic purpose.

Common Questions

What makes MOTS-C unique among research peptides?
MOTS-C is encoded in mitochondrial DNA rather than nuclear DNA — a rare distinction among peptides. This makes it a subject of interest in research on mitochondria-to-nucleus communication (retrograde signaling) as well as metabolic regulation.
What sizes is MOTS-C available in?
J.Pharma carries MOTS-C in 10mg and 40mg vials. The 40mg is the large-format option for extended research protocols.
How do I reconstitute MOTS-C?
Use Bacteriostatic Water. For 10mg: 1 mL BAC Water (10 mg/mL). For 40mg: 4 mL BAC Water (10 mg/mL). The solution is clear and colorless. Refrigerate after reconstitution, stable 28–42 days at 2–8°C.
What is AMPK and why is it relevant to MOTS-C research?
AMPK (AMP-activated protein kinase) is a master regulator of cellular energy balance. When activated, it promotes glucose uptake, fatty acid oxidation, and mitochondrial biogenesis while suppressing anabolic processes that consume energy. MOTS-C research has shown it activates AMPK, which is the basis for its metabolic research applications.

Related Compounds

Regulatory Notice

None of the statements on this website have been reviewed or approved by the U.S. Food and Drug Administration. J.Pharma products are not intended to diagnose, treat, cure, or prevent any disease or medical condition. All products are sold strictly for in vitro laboratory research purposes. They are not for human or animal use of any kind. DiPerna Services, LLC d/b/a J.Pharma is not a compounding pharmacy or outsourcing facility as defined under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act.